| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 05/02/2002 | WO2001023375A3 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/02/2002 | WO2001009121A3 2-pyrazolin-5-ones_as tyrosine kinase inhibitors |
| 05/02/2002 | US20020052721 Data driven layout engine |
| 05/02/2002 | US20020052514 1-(phenylmethyl)sulfonyl-2-hydroxymethyl pyrrolidine for example; use treating neurological disorders including physically damaged nerves and neurodegenerative diseases; treating alopecia and promoting hair growth |
| 05/02/2002 | US20020052510 N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres |
| 05/02/2002 | US20020052496 Novel 1-(N'-(arylalkylaminoalkyl)) aminoisoquinolines: a new class of dopamine receptor subtype |
| 05/02/2002 | US20020052495 Pyramidine or triazine derivatives which specifically inhibit the binding of endothelin to the receptor |
| 05/02/2002 | US20020052398 Pharmaceutical composition of 6-amino EM-12 |
| 05/02/2002 | US20020052397 Treatment of diseases characterized by excess Th2 cytokines and/ or an excess IgE production. |
| 05/02/2002 | US20020052386 Pyrimidine derivatives |
| 05/02/2002 | US20020052380 Piperazinone-containing compounds; treatment of cancer, blindness due to retinal vascularization, hepatitus delta, polycystic kidney disease, prevention of restinosis |
| 05/02/2002 | US20020052375 3-(Heteroaryal) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 |
| 05/02/2002 | US20020052369 Indolinone derivatives as protein kinase/phosphatase inhibitors |
| 05/02/2002 | US20020052358 Methods and compositions related to modulators of annexin and cartilage homeostasis |
| 05/02/2002 | EP1201664A1 Benzimidazole compounds and drugs containing the same |
| 05/02/2002 | EP1201661A1 Heteroaromatic ring compounds |
| 05/02/2002 | EP1200824A1 Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives |
| 05/02/2002 | EP1200430A1 Thiourea and isothiourea derivatives for inhibiting ras-transformed cell growth |
| 05/02/2002 | EP1200429A1 1-cycloalkylpyrazoyl-benzoyl derivatives |
| 05/02/2002 | EP1200427A2 Small molecule modulators of g protein-coupled receptor six (gpr6) |
| 05/02/2002 | EP1200424A1 C7 heterosubstituted acetate taxanes as antitumor agents |
| 05/02/2002 | EP1200422A2 Pyrazole compositions useful as inhibitors of erk |
| 05/02/2002 | EP1200415A1 Diamino-1,2,4-triazole-carboxylic acid derivatives as gsk-3 inhibitors |
| 05/02/2002 | EP1200414A1 Process for the preparation of substituted pyrimidines |
| 05/02/2002 | EP1200084A1 Use of an angiotensin ii type 1 receptor antagonist in the manufacture of a medicament for the treatment of cardiovascular complications |
| 05/02/2002 | EP1200072A2 Method of treating psychotic disorders |
| 05/02/2002 | EP0918758B1 Process for preparing 1-substituted 4-cyano-1,2,3-triazoles |
| 05/02/2002 | EP0840740B1 New inhibitors of platelet aggregation |
| 05/02/2002 | DE10051981A1 Substituierte Phenyluracile Substituted Phenyluracils |
| 05/02/2002 | CA2426674A1 Agent for preventing or treating portal hypertension |
| 05/02/2002 | CA2425884A1 Substituted phenyluracils |
| 05/02/2002 | CA2425288A1 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/02/2002 | CA2425280A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | CA2420727A1 Triazole derivatives and pharmaceutical compositions comprising them |
| 05/01/2002 | CN1347414A Triazole compounds with dopamine-D3-receptor affinity |
| 05/01/2002 | CN1346830A Novel 2,4-dioxopyrrolidone and 2,4-dioxotetrahydro-furan derivs. and medicine contg. them as active component |
| 05/01/2002 | CN1346826A Microbicidal halobenzoimidazole, composition and process for preparing same |
| 04/30/2002 | US6380398 Compounds such as (s,s)1-(2-amino-3,3-dimethyl-butyryl)-2,5-dihydro-1h-pyrrole-2 -carbonitrile administered as antidiabetic agents; dipeptidyl peptidase-iv (dpp-iv) |
| 04/30/2002 | US6380242 For diagnosis and therapy of central nervous system conditions |
| 04/30/2002 | US6380241 For therapy of coronary angina, cerebral vasospasm, acute and chronic renal failure, gastric ulceration, cyclosporin-induced nephrotoxicity, endotoxin-induced toxicity, asthma, lpl-related lipoprotein disorders, proliferative diseases |
| 04/30/2002 | US6380233 Indole derivatives as 5-HT1 agonists |
| 04/30/2002 | US6380231 For controlling animal and fungal pests |
| 04/30/2002 | US6380226 For therapy of migraine, cluster headache, chronic paroxysmal hemicrania or headache associated with a vascular disorder, depression, anxiety, an eating disorder, obesity, drug abuse, hypertension and emesis |
| 04/30/2002 | US6380225 Microbicidal benzotriazoles |
| 04/30/2002 | US6380215 For prevention and/or treatment of diseases caused by thrombus formation such as arterial thrombosis, arterial sclerosis, ischemic heart diseases |
| 04/30/2002 | US6380205 2-cyclohexyl quinazoline NMDA/NR2B antagonists |
| 04/30/2002 | US6380201 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists |
| 04/30/2002 | US6380194 For treatment of subjects suffering from hiv infection |
| 04/30/2002 | US6380186 Psychotherapeutic agents |
| 04/30/2002 | US6380184 For increased production of wool, milk, and meat by treating animals with therapeutically effective amount of compound |
| 04/30/2002 | US6380180 Potassium channel blocking agents |
| 04/30/2002 | US6379882 Exposing a primary culture of retinal ganglion cells to an oxygen/glucose deprivation challenge with and without a test compound; after an incubation period, measure the percentage of apoptotic cells |
| 04/30/2002 | US6379823 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye |
| 04/30/2002 | US6379655 For protection of human skin and/or hair against the damaging effects of ultraviolet irradiation |
| 04/30/2002 | CA2246994C Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl)¬1,4|diazepan-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 04/30/2002 | CA2241827C Novel substituted 4-(1h-benzimidazol-2-yl)¬1,4|diazepanes useful for the treatment of allergic diseases |
| 04/30/2002 | CA2131761C Crystals of pyridonecarboxylic acid derivative |
| 04/25/2002 | WO2002032900A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 04/25/2002 | WO2002032882A1 Process for producing substituted aniline compound |
| 04/25/2002 | WO2002032864A1 Pharmaceutically active sulfanilide derivatives |
| 04/25/2002 | WO2002032863A1 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
| 04/25/2002 | WO2002032422A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | WO2002032416A2 Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists |
| 04/25/2002 | WO2002010137A3 Indazole derivatives as JNK inhibitors |
| 04/25/2002 | WO2001058891A3 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage |
| 04/25/2002 | WO2001002369A3 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 04/25/2002 | US20020049322 Quinoline and quinazoline compounds useful in therapy |
| 04/25/2002 | US20020049246 Benzimidazole compounds for treatment of asthma, vasospasm, memory loss, migraine and others diseases associated with potassium channels |
| 04/25/2002 | US20020049243 Pyrrolidine derivatives |
| 04/25/2002 | US20020049239 Novel indole and benzothiazole derivatives |
| 04/25/2002 | US20020049231 S(-)-3-aminothalidomide; treating wide variety of diseases including diabetic retinopathy |
| 04/25/2002 | US20020049227 Pyrazoles and pyrazolopyrimidines having crf antagonistic activity |
| 04/25/2002 | US20020049221 Analogs of deoxypreussomerin, palmarumycin CPI and related naphthoquinone spiroketals; inhibit thioredoxin-thioredoxin reductase system |
| 04/25/2002 | US20020049220 Substituted azoles |
| 04/25/2002 | US20020049217 Peptidomimetic macrocyclic compounds which inhibit prenyl-protein transferase and the prenylation of the oncogene protein Ras |
| 04/25/2002 | US20020049209 Dopamine D4 ligands for the treatment of novelty-seeking disorders |
| 04/25/2002 | US20020049205 Pyrazole antimicrobial agents |
| 04/25/2002 | US20020049194 A benzoazepin or benzodiazepin derivatives, shows excellent anti-vasopressin activity, vasopressin agonistic activity and oxytocin antagonistic activity, and are useful as antagonist |
| 04/25/2002 | US20020049193 Inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity. |
| 04/25/2002 | DE10050492A1 New butenolide or pentenolide amide derivatives, useful as kinase inhibitors for treating inflammatory and autoimmune diseases, e.g. rheumatoid arthritis, asthma, Alzheimer's disease or osteoarthritis |
| 04/25/2002 | DE10050490A1 New butenolide or pentenolide amide derivatives, useful as kinase inhibitors for treating inflammatory and autoimmune diseases, e.g. rheumatoid arthritis, asthma, Alzheimer's disease or osteoarthritis |
| 04/25/2002 | CA2426487A1 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | CA2423933A1 Pharmaceutically active sulfanilide derivatives |
| 04/25/2002 | CA2422717A1 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
| 04/24/2002 | EP1199307A1 Pharmaceutically active benzoquinazoline compounds |
| 04/24/2002 | EP1198453A2 N-(indolcarbonyl-)piperazin derivatives |
| 04/24/2002 | EP0782568B1 Aromatic ethers derived from indols such as 5ht1-like ligands |
| 04/24/2002 | EP0714299B1 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
| 04/24/2002 | CN1346355A Novel inhibitors of farnesyl-protein transferase |
| 04/24/2002 | CN1346354A Substituted benzoylpyrazoles as herbicides |
| 04/24/2002 | CN1346353A Farnesy transferase inhibitors having a pyrrole structure and process for preparation thereof |
| 04/24/2002 | CN1346350A Compound which inhibiti leukocyte adhesion mediated by VLA-4 |
| 04/24/2002 | CN1346348A Amide compounds and medicinal use thereof |
| 04/24/2002 | CN1346282A Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as combination therapy method in treating neoplasia |
| 04/24/2002 | CN1346271A Quinazoline derivatives as angiogenesis inhibitors |
| 04/24/2002 | CN1083450C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides |
| 04/24/2002 | CN1083443C 吲哚衍生物 Indole derivatives |
| 04/24/2002 | CN1083439C 2-amino-4-bicyclomino-1,3,5-triazines as herbicides and plant growth regulators |
| 04/24/2002 | CN1083438C Substituted dismino-1,3,5-triazine derivatives |
| 04/24/2002 | CN1083437C 2-[1',2',4'-triazol-3'-yloxymethylenel anilides,] their preparation and use |